Monthly Archiv: July, 2018

Este es el Efecto de la Garcinia Cambogia Para Bajar de Peso

Este es el Efecto de la Garcinia Cambogia Para Bajar de Peso

La garcinia cambogia es un fruto asiático que se ha vuelto popular, gracias a su efecto para perder peso de manera efectiva. Checa su poder a favor de tu silueta.

¿Cómo actúa?
Suprime el apetito y bloquea una enzima, cuya función es la de transformar los carbohidratos en grasa. Además, provoca un sensación de saciedad para no comer en exceso.

Otros beneficios:
– Te pone de buen humor (eleva los niveles de serotonina)

– Regula los niveles de colesterol

– Es antioxidante

– Alivia la acidez estomacal

– Protege al corazón

– Hidrata la piel

– Reduce la ansiedad por comer

– Acelera el metabolismo

– Fortalece el sistema inmune

– Inyecta energía

– Mejora la circulación sanguínea

Hasta ahora no se le han encontrado efectos secundarios y su el consumo deGarcinia Cambogia no implica algún tipo de riesgo para la salud.

Sin embargo, hay personas para las que no es recomendada, por ejemplo, las mujeres embarazadas o personas con problemas del corazón, pues acelera la frecuencia cardíaca.

La Garcinia Cambogia se consume comúnmente en comprimidos que puedes encontrar en las tiendas naturistas. No lo olvides, antes de tomar cualquier producto, consúltalo con tu médico.

 

Article source: http://www.cdnoticias.com.mx/articulos/este-efecto-la-garcinia-cambogia-bajar-peso-2/salud

Garcinia Cambogia Extract Market Expected to Witness a Sustainable Growth over 2027

Garcinia Cambogia a small, sweet tropical tree fruit also known as Malabar tamarind. Other names for Garcinia Cambogia are Assam Fruit, Gorakkapulli, Panampulli, Manda Huli, Goraka Pulli, Mangosteen, and Vadakkan Puli. Garcinia Cambogia is obtained in different colors depending on the spices such as yellow, green and red. Garcinia Cambogia extract is a hub of vitamins B, Thiamin, Folic Acid, Niacin, Magnesium, Vitamin C, Manganese, Potassium and Hydroxycitric Acid (HCA).

Hydroxycitric Acid in Garcinia Cambogia Extract is appetite suppressant which reduces cravings and decrease the urge to consume calories. Hydroxycitric Acid also helps in managing stress hormones, increase serotonin level, speed up metabolism leading to better mood sleep and reduce belly fat. Garcinia Cambogia Extract not only improves your overall health, but also prohibits the conversion of calories into fat. Hydroxycitric Acid inhibits the production of an enzyme that slows down the metabolism rate of the body. Because of this, the body converts the extra calories into glycogen. Garcinia Cambogia extract also helps the body to build more muscles.

Market Segmentation: Garcinia Cambogia Extract market is segment on the basis of form, distribution channel and region. On the basis of form market is segmented into powder, capsule and liquid.Garcinia Cambogia Extract come in different forms but the most popular form is the powdered form. Weight loss has become a common desire for many people these days and with huge rage of alternatives available it becomes quite difficult task for consumers to select one which they want for themselves. Exactly what makes garcinia cambogia extract powder hugely popular is the fact that it is natural, safe to consume and has proven positive results for weight loss.

Garcinia cambogia extract powder with 100% HCA is probably the best remedies for weight loss. On the basis of distribution channel the market is segmented into supermarkets/hypermarkets, convenience stores, medical stores and online stores. Online Stores is expected to hold a relatively high share in the garcinia cambogia extract market. Medical stores have also contributed significantly to the growth of Garcinia cambogia extract market over the forecast period. On the basis of region garcinia cambogia extractmarket is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, MEA and Japan.

Market Regional Outlook: Regional segment for the market of asparagus is divided into seven different regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, MEA and Japan. Among these segment Asia Pacific is expected to have the major market share globally, as it is the largest consumer of garcinia cambogia extract. In Asia Pacific region the India is generating the major revenue. In terms of revenue Africa is the second prominent contributor in the garcinia cambogia extractmarket.

Market Drivers: The rise in demand for weight loosing supplement is expected to drive the growth of global garcinia cambogia extract market. Garcinia cambogia extract is not only used as a supplement for weight reduction but it also exhibits some special properties such as it helps to reduce the cortisol level, reduce risk of heart disease, reduce risk of ulcer and improve lipid profile. It also helps in maintaining better metabolism and better cardiovascular health.

The versatile properties of garcinia cambogia extracthas defiantly attracted the pharmaceutical companies which will drive the garcinia cambogia extract market to a greater extent.Moreover, the market is also driven by the increasing awareness among the consumers about the health benefits associated with garcinia cambogia extract.

Market Key Players: Some of the key players in garcinia cambogia extractmarket are Power up health, BioGanix, Nature wise, Naturabest, NOW Foods, Top Secret Nutrition, Natrol, Global Health Ideas, Quality Encapsulations, shape organics,Search Results, Potent Organics, St.Botanica, Healthawin, Whole Body Research, NutriRise, PureNutria, Gaia Science? and  Morpheme Remedies among others.

Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2587

Article source: http://364analyze.com/2018/07/16/garcinia-cambogia-extract-market-expected-to-witness-a-sustainable-growth-over-2027/

Oz & Roizen: Supplements to avoid when taking SSRI drugs for depression

I’m taking the serotonin-reuptake inhibitor sertraline (Zoloft) for depression. I feel so much better, and I assumed it was OK to keep taking my vitamins. But are there supplements I should watch out for? — Cecilia H., Ossining, New York

Congrats on taking charge of your depression and feeling better. Yes, there are certain supplements that interfere with selective serotonin-reuptake inhibitors (SSRIs), and with serotonin and noradrenalin reuptake inhibitors (SNRIs) too.

Serotonin is a neurotransmitter found in your gut, your blood and your nervous system. It’s considered a natural mood stabilizer. You probably weren’t getting the right balance, and the sertraline has helped you re-establish that! Since we don’t know your exact dosage or the supplements you are taking, we can’t directly answer your question. You should talk to your doctor about all the supplements and herbal preparations you may be using. When you do, here are some specifics to discuss:

• Ask your doctor about the risks of taking St. John’s wort, garcinia cambogia, L-tryptophan (or 5-HTP) and SAMe (S-adenosyl-methionine) supplements with your antidepressant. Consumer Labs says they can increase your risk of experiencing serotonin syndrome. That’s when there’s an overabundance of serotonin in your system that triggers everything from goosebumps and shivering to muscle rigidity, diarrhea and heavy sweating. (If that happens, do not ever abruptly stop taking your SSRI or SNRI!)

• Also ask about the potential benefits of these supplements: A study in the American Journal of Psychiatry found that omega-3 fish oil (specifically EPA) in combo with SSRIs caused a significant reduction in depressive symptoms. It was also true to a lesser extent for vitamin D and methylfolate, a form of folic acid.

I was on a plane, and the person next to me was watching one of the latest action movies. I won’t single it out, but it was nonstop violence — and rated PG-13! How can this not negatively affect impressionable youngsters? — Jesse J., Sioux Falls, South Dakota

The Motion Picture industry has eroded standards so that the PG-13 rating (parents strongly cautioned, for children under 13) means next to nothing. The Harvard School of Public Health warned that a “ratings creep” (it’s a voluntary system) has allowed more violent and sexually explicit content into films that are seen by young teens. Recently, the American Academy of Pediatrics reported that gun violence in PG-13-rated films has more than tripled since 1985. And public health and mental health experts agree that nonstop violence in films (and on TV and in video games) can make kids more aggressive and damage their emotional development. So our advice to parents:

1. Do diligent research when your teen wants to see a movie. Find out how much and what type of violence a film contains, and check out Common Sense Media (commonsensemedia.org). In its Parents’ Guide, it gives ratings for categories such as positive messages, positive role models, sex, violence, language, drinking, drugs and smoking, and a review.

Here’s a partial review of the Cohen Brothers’ adaptation of the Western “True Grit,” which is rated PG-13. CommonSense gave it an age 15+. They say: “impressive and forceful, but it’s also full of brutal (and sometimes bloody) gunfight sequences and other violent moments that aren’t appropriate for younger viewers … mature teens are likely to feel a kinship with the lead character, 14-year-old Mattie Ross …They might even learn from her adventure … lessons … dealing with loyalty, courage and determination.”

2. Ask around and find out what other parents have to say. If you’re not sure about the content, watch the movie first or watch with your youngster.

3. Talk to your kids about violence in the media. Help them evaluate what is gratuitous and reject its message. Remember, if teens want to see a movie, with all the streaming available these days, chances are they will, even if you say no. So be proactive and help them avoid the upsetting and mind-bending violence that’s out there.

Mehmet Oz, M.D. is host of “The Dr. Oz Show,” and Mike Roizen, M.D. is Chief Wellness Officer and Chair of Wellness Institute at Cleveland Clinic.

Article source: http://www.onlineathens.com/news/20180716/oz-amp-roizen-supplements-to-avoid-when-taking-ssri-drugs-for-depression

Quarterly Updates | Q2 2018

To keep everyone aware of big projects and efforts across WordPress contributor teams, I’ve reached out to each team’s listed representatives. I asked each of them to share their Top Priority (and when they hope for it to be completed), as well as their biggest Wins and Worries. Have questions? I’ve included a link to each team’s site in the headings.

Accessibility

  • Contacted: @rianrietveld, @joedolson, @afercia
  • Priority: Working to make sure that Gutenberg is reasonably accessible prior to merge. ETA is before 5.0
  • Struggle: Lack of developers and accessibility experts to help test and code the milestone issues. The team is doing outreach to help solve this problem.
  • Big Win: Interest from companies like The Paciello Group and Tenon.io to help out with Gutenberg code review and testing tools.

CLI

  • Contacted: @danielbachhuber, @schlessera
  • Priority: Very first global Hack Day is coming up July 20. Version 2.0.0 is still in progress (new ETA is end of July).
  • Struggle: The team continues to need new contributors. The current team is tiny but tough.
  • Big Win: WP-CLI is currently one of the project’s four main focuses, as mentioned in the Summer Update at WordCamp Europe.

Community

  • Contacted: @francina, @hlashbrooke
  • Priority: Focusing on smoothing out the processes in our community management by building up our team of volunteers and establishing what tools we need to keep things running well. ETA is ongoing.
  • Struggle: Our two biggest struggles at the moment are tracking what we need to get done, and making final decisions on things. There is current work on the tools available to assist with tracking progress.
  • Big Win: After making a concerted effort to get more contributors on the Community Team, we now have a much larger group of volunteers working as deputies and WordCamp mentors

Core

  • Contacted: @jeffpaul
  • Priority: Following the WordCamp Europe summer update (and the companion post here), the team is getting Gutenberg (the new WordPress editing experience) into a strong state for the 5.0 release. Potential ETA as soon as August.
  • Struggle: Coordinating momentum and direction as we start seeing more contributors offering their time. Still working our way through open issues. The team is starting multiple bug scrubs each week to work through these more quickly and transparently.
  • Big Win: Had a sizable release in 4.9.6 which featured major updates around privacy tools and functionality in Core.

Design

  • Contacted: @melchoyce, @karmatosed, @boemedia, @joshuawold, @mizejewski
  • Priority: Better on-boarding of new contributors, especially creating better documentation. ETA is end of July.
  • Struggle: It’s hard to identify reasonably small tasks for first-time contributors.
  • Big Win: The team is much more organized now which has helped clear out the design backlog, bring in new contributors, and also keep current contributors coming back. Bonus: Joshua Wold will co-lead the upcoming release.

Documentation

  • Contacted: @kenshino
  • Priority: Opening up the work on HelpHub to new contributors and easing the onboarding process. No ETA.
  • Struggle: Some blockers with making sure the code and database can be ready to launch on https://wordpress.org/support/
  • Big Win: The first phase of HelpHub creation is complete, which means content updates (current info, more readable, easier discovery), internal search, design improvements, and REST API endpoints.

Hosting

  • Contacted: @mikeschroder, @jadonn
  • Priority: Preparing hosts for supporting Gutenberg, especially support questions they’re likely to see when the “Try Gutenberg” callout is released. ETA July 31st, then before WordPress 5.0
  • Struggle: Most contributions are still made a by a small team of volunteers. Seeing a few more people join, but progress is slow.
  • Big Win: New team members and hosting companies have joined the #hosting-community team and have started contributing.

Marketing

  • Contacted: @bridgetwillard
  • Priority: Continuing to write and publish case studies from the community. ETA is ongoing.
  • Struggle: No current team struggles.
  • Big Win: Wrote and designed a short Contributor Day onboarding card. It was used at Contributor Day at WCEU and onboarding time went down to 1 hour instead of 3 hours.

Meta (WordPress.org Site)

  • Contacted: @tellyworth, @coffee2code
  • Priority: Reducing manual work around the contributor space (theme review, GDPR/privacy, plugin review). ETA for small wins is end of quarter, larger efforts after that.
  • Struggle: Maintaining momentum on tickets. There are also some discussions about updating the ticket management process across teams that use the Meta trac system.
  • Big Win: The new About page launched and has been translated across most locale sites.

Mobile

  • Contacted: @elibud
  • Priority: Getting Gutenberg in the mobile applications. ETA is late December.
  • Struggle: Consuming the Gutenberg source in the ReactNative app directly. More info can be found here: https://make.wordpress.org/mobile/2018/07/09/next-steps-for-gutenberg-mobile/
  • Big Win: The WordPress mobile applications now fully support right-to-left languages and are compliant with the latest standards for accessibility.

Plugins

  • Contacted: @ipstenu
  • Priority: Clearing ~8,000 unused plugins from the queues. Likely ETA is September.
  • Struggles: Had to triage a lot of false claims around plugins offering GDPR compliance.
  • Big Win: Released 4.9.6 and updated expectations with plugin authors. Huge thanks to the Core Privacy team for their hard work on this.

Polyglots

  • Contacted: @petya, @ocean90, @nao, @chantalc, @deconf, @casiepa
  • Priority: Keep WordPress releases translated to 100% and then concentrate on the top 100 plugins and themes. ETA is ongoing.
  • Struggle: Getting new PTEs fast enough, and complex tools/systems. Overall, the volume of strings awaiting approval.

Support

  • Contacted: @clorith
  • Priority: Getting ready for the Gutenberg callout (it got pushed last quarter). Needing a better presence on the official support forums, and outreach for that is underway, ETA end of July. 
  • Struggle: Keeping contributors participating post-contributor days/drives. Considering the creation of a dedicated post-contributor day survey to get some insight here.
  • Big Win: The increase in international liaisons joining for weekly meetings, helping bring the wider support community together.

Theme Review

Tide

  • Contacted: @valendesigns (but usually @jeffpaul)
  • Priority: Storing PHPCompatibilty results inside the WordPress.org API and building a UI to display those results, an endpoint to request an audit is required for this work to continue.
  • Struggle: Development has dramatically slowed down while team members are on leave or pulled into internal client work.
  • Big Win: Migration to Google Cloud Platform (GCP) from Amazon Web Services (AWS) is complete and the audit servers have all been rewritten in Go. (This allows us to be faster with greater capacity and less cost.)

Training

  • Contacted: @bethsoderberg, @juliek
  • Priority: Lesson plan production. ETA is ongoing.
  • Struggle: The workflow is a little complex, so recruiting and training enough contributors to keep the process moving is a struggle.
  • Big Win: WordCamp Europe’s Contributor Day was very productive. New tools/workflow are in place and two team representatives were there to lead and help.

Interested in updates from the first quarter of this year? You can find those here: https://make.wordpress.org/updates/2018/04/24/quarterly-updates-q1-2018/

Regentatlantic Capital Has Trimmed United Therapeutics Del (UTHR) Holding By $423024; NUTRAFUELS (NTFU …

<!–

Market News

–>

July 15, 2018 – By Mary Kidd

United Therapeutics Corporation (NASDAQ:UTHR) Logo

NUTRAFUELS INC (OTCMKTS:NTFU) had a decrease of 37.5% in short interest. NTFU’s SI was 2,500 shares in July as released by FINRA. Its down 37.5% from 4,000 shares previously. The SI to NUTRAFUELS INC’s float is 0.01%. The stock increased 5.00% or $0.01 during the last trading session, reaching $0.21. About 19,490 shares traded. NutraFuels, Inc. (OTCMKTS:NTFU) has 0.00% since July 15, 2017 and is . It has underperformed by 12.57% the SP500.

Regentatlantic Capital Llc decreased United Therapeutics Corp Del (UTHR) stake by 30.94% reported in 2018Q1 SEC filing. Regentatlantic Capital Llc sold 3,777 shares as United Therapeutics Corp Del (UTHR)’s stock declined 10.66%. The Regentatlantic Capital Llc holds 8,432 shares with $947,000 value, down from 12,209 last quarter. United Therapeutics Corp Del now has $5.43B valuation. The stock increased 0.48% or $0.6 during the last trading session, reaching $124.74. About 125,357 shares traded. United Therapeutics Corporation (NASDAQ:UTHR) has declined 12.46% since July 15, 2017 and is downtrending. It has underperformed by 25.03% the SP500. Some Historical UTHR News: 02/05/2018 – Analytic Investors LLC Exits Position in United Therapeutics; 02/05/2018 – United Therapeutics 1Q Adj EPS $3.76; 02/05/2018 – UNITED THERAPEUTICS 1Q ADJ. EPS 3.76, EST. $3.56; 30/04/2018 – United Therapeutics: Milestone Related to Commercialization of Trevyent; 26/03/2018 Roger Jeffs, Former Co-CEO of United Therapeutics, Joins Pluristem’s Strategic Advisory Board; 30/04/2018 – UNITED THERAPEUTICS: DEAL VALUED AT $216M; 30/04/2018 – United Therapeutics to Buy SteadyMed — Deal Digest; 30/04/2018 – United Therapeutics to Buy SteadyMed for $4.46/Share Cash at Closing; 30/04/2018 – United Therapeutics To Acquire SteadyMed Ltd. STDY; 02/05/2018 – United Therapeutics 1Q Net $244.5M

NutraFuels, Inc. manufactures and distributes oral spray nutritional and dietary products to retail and wholesale outlets. The company has market cap of $17.92 million. The companyÂ’s products include sleep spray to support a healthy sleep cycle and improve the quality of restful sleep; energize spray to enhance energy, and restore vigor and vitality; and garcinia cambogia spray, an appetite and weight management spray. It currently has negative earnings. It also offers NRG-X extreme energy spray to enhance energy and stamina; headache and pain spray to relieve headaches and pain; and hair, skin, and nails spray to nourish and encourage hair, skin, and nail growth.

Since March 14, 2018, it had 0 insider buys, and 12 selling transactions for $27.22 million activity. ROTHBLATT MARTINE A had sold 21,512 shares worth $2.42 million. Olian Judy D. had sold 600 shares worth $67,425. Another trade for 3,240 shares valued at $366,353 was sold by DWEK RAYMOND.

Among 3 analysts covering United Therapeutics (NASDAQ:UTHR), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. United Therapeutics had 9 analyst reports since January 19, 2018 according to SRatingsIntel. The stock of United Therapeutics Corporation (NASDAQ:UTHR) has “Underperform” rating given on Thursday, February 22 by Credit Suisse. The stock of United Therapeutics Corporation (NASDAQ:UTHR) earned “Neutral” rating by Credit Suisse on Tuesday, April 3. Credit Suisse maintained the shares of UTHR in report on Thursday, May 3 with “Neutral” rating. The firm has “Underweight” rating by Barclays Capital given on Thursday, May 3. The stock has “Buy” rating by Wedbush on Friday, May 4. The firm earned “Neutral” rating on Tuesday, July 10 by Credit Suisse. Barclays Capital maintained the stock with “Underweight” rating in Thursday, February 22 report. As per Tuesday, February 27, the company rating was maintained by Wedbush.

Another recent and important United Therapeutics Corporation (NASDAQ:UTHR) news was published by Globenewswire.com which published an article titled: “Factors of Influence in 2018, Key Indicators and Opportunity within Dr Pepper Snapple Group, United Therapeutics …” on June 25, 2018.

Analysts await United Therapeutics Corporation (NASDAQ:UTHR) to report earnings on July, 26. They expect $2.57 earnings per share, up 305.60% or $3.82 from last year’s $-1.25 per share. UTHR’s profit will be $111.91M for 12.13 P/E if the $2.57 EPS becomes a reality. After $5.57 actual earnings per share reported by United Therapeutics Corporation for the previous quarter, Wall Street now forecasts -53.86% negative EPS growth.

Regentatlantic Capital Llc increased Jpmorgan Chase Co (AMJ) stake by 82,677 shares to 1.45M valued at $34.89 million in 2018Q1. It also upped Dxc Technology Co stake by 42,754 shares and now owns 94,047 shares. Vanguard Index Fds (VOO) was raised too.

Investors sentiment decreased to 0.87 in Q1 2018. Its down 0.27, from 1.14 in 2017Q4. It fall, as 33 investors sold UTHR shares while 124 reduced holdings. 41 funds opened positions while 96 raised stakes. 40.96 million shares or 0.16% more from 40.90 million shares in 2017Q4 were reported. Advisory Svcs Network Lc accumulated 100 shares. Archford Cap Strategies Limited Liability Corp has 6 shares. Old Bancshares In holds 0.02% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR) for 3,434 shares. Strategic Advsrs Ltd Llc has 0.38% invested in United Therapeutics Corporation (NASDAQ:UTHR) for 9,990 shares. Pictet Asset Management holds 0.03% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR) for 111,139 shares. Wellington Grp Inc Llp reported 9,375 shares stake. Moreover, Korea Invest Corp has 0.03% invested in United Therapeutics Corporation (NASDAQ:UTHR) for 64,056 shares. South Dakota Investment Council reported 0.13% stake. Brown Advisory, Maryland-based fund reported 3,000 shares. Retirement Of Alabama invested in 0.03% or 55,923 shares. Apg Asset Mgmt Nv has 0.12% invested in United Therapeutics Corporation (NASDAQ:UTHR). Caisse De Depot Et Placement Du Quebec has 0% invested in United Therapeutics Corporation (NASDAQ:UTHR). Convergence Investment Prtnrs holds 0% or 149 shares in its portfolio. California State Teachers Retirement System stated it has 0.02% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR). Liberty Mutual Group Asset Mgmt invested 0.03% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR).

United Therapeutics Corporation (NASDAQ:UTHR) Institutional Positions Chart

Receive News Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Article source: https://cardinalweekly.com/regentatlantic-capital-has-trimmed-united-therapeutics-del-uthr-holding-by-423024-nutrafuels-ntfu-sellers-decreased-by-37-5-their-shorts/

Amy Schumer Takes Down Diet Fads in This Exclusive ‘I Feel Pretty’ Deleted Scene

Amy Schumer is not about that diet life in this exclusive deleted scene from the I Feel Pretty Blu-ray, which is available starting Tuesday, July 17.

After suffering a bump on the head, Renée (Schumer) gains a new perspective on her body and begins to live her life free from the bonds of body-image issues. When she sits down for a meal with her work friends and notices that they’re both trying to control their weight using some questionable diet fads, she gives them some advice based on her years of experience.

“Let me guess, eight-day juice cleanse,” she says as one friend sips a green concoction and nods. “I’ve been there. And then every night they give you that sweet little almond milk and it’s supposed to be like a treat at the end of the day, but it really just feels like an eff you.”

@BritandCo!

(photo via Mark Schafer/Motion Picture Artwork)

Article source: https://www.brit.co/exclusive-deleted-scene-i-feel-pretty/

Powered by Gewgley